Biotechnology industry
Q1FY271 earlier
6 companies · ₹56,120 cr · 2 with AI deep dives · Q1FY27 report
Exhibit 3Structure
₹56,120 crAnthem Biosciences Ltd is 93.7% of this industry by market cap. The top 5 are 100% and the top 10 are 100%.
large 1small 1micro 42 above ₹500 cr
Exhibit 5Coverage (6 of 6)
Every company here with a deep dive, topped up by market cap. The rest of the industry is in the appendix.
- Mcap
- ₹3,293 cr
- P/E
- 19.8x
- EV/EBITDA
- 12.0x
- ROCE
- 13.6%
- Margin
- 34.7%
- Rev YoY
- +2.1%
Exhibit 6What managements said
from Pharmaceuticals & Biotechnology earnings calls · as of 2026-06-30tailwindIndia branded formulations delivering broad-based IPM outperformance10 managements
Every covered India-branded company reported revenue growth exceeding IPM in Q1 FY27. Sun (+16%, volume 5.4% vs IPM 2%), Torrent (+19% base vs IPM 12%), Zydus (+20%), Cipla…
- TORNTPHARM (Q1FY27): “Torrent's India base business revenues for Q1 were INR2,157 crores, registering a growth…”
headwind8 managementstailwind7 managementsheadwind5 managementsheadwind4 managementsmixed4 managementstailwind5 managementsmixed4 managements
7 more themes from this quarter's earnings calls are locked. A free account opens 3 full reports a quarter: every theme with verbatim management quotes, the demand picture, companies running against the tide, and the regulatory & disruption watch. Sign up free →
Exhibit 7Outlook
The outlook and what resolves next quarter
Where these managements said things are heading, and the dated, checkable events that would change it. Free with an account - 3 full reports a quarter.
Create a free account →